Aduro BioTech Inc Logo Image

Aduro BioTech Inc

Aduro BioTech Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Aduro BioTech Inc

Aduro BioTech Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Aduro BioTech Inc

51-200 Employees
Based in Berkeley, California

Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol